Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: A population-based study

International Journal of Radiation Oncology Biology Physics

Volumn 56, Issue 4, 2003, Pages 1038-1045

  Gao, Xiang ^a,d   Fisher, Susan G ^b   Emami, Bahman ^c  

^a Ctrl AR Radiation Therapy Institute   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF ARKANSAS SYSTEM   (United States)

Author keywords

Contralateral breast cancer; Prevention; Race; Radiotherapy; Second malignancies

Indexed keywords

CHEMOTHERAPY; ESTIMATION; PATIENT TREATMENT; POPULATION STATISTICS; RISK ASSESSMENT;

PRIMARY CANCER;

TUMORS;

HORMONE;

ACUTE DISEASE; ADULT; AGE; AGED; ARTICLE; ASSAY; BREAST CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER INVASION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CANCER THERAPY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; DOCUMENTATION; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; MEDULLARY CARCINOMA; MULTIVARIATE ANALYSIS; NEGRO; NONBIOLOGICAL MODEL; POPULATION; PRIORITY JOURNAL; RACE; RADIATION DOSE; STATISTICAL ANALYSIS;

EID: 0037710394     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(03)00203-7     Document Type: Article

References (66)

1. Jemal A., Murray T., Samuels A., et al. Cancer statistics, 2003. CA Cancer J Clin. 53:2003;5-26.
2. Boice J.D. Jr, Land C.E., Shore R.E., et al. Risk of breast cancer following low-dose radiation exposure. Radiology. 131:1979;589-597.
3. Boice J.D. Jr, Preston D., Davis F.G., et al. Frequent chest x-ray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts. Radiat Res. 125:1991;214-222.
4. Boice J.D. Jr, Mandel J.S., Doody M.M. Breast cancer among radiology technologists. JAMA. 274:1995;394-401.
5. Land C.E., Boice J.D. Jr, Shore R.E., et al. Breast cancer risk from low-dose exposure to ionizing radiation. J Natl Cancer Inst. 65:1980;353-376.
6. Bhatia S., Robinson L.L., Oberlin O., et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med. 334:1996;745-751.
7. Miller A.B., Howe G.R., Sherman G.J., et al. Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis. N Engl J Med. 321:1989;1285-1289.
8. Shapiro C.L., Mauch P.M. Radiation-associated breast cancer after Hodgkin's disease Risks and screening in perspective . J Clin Oncol. 10:1992;1662-1665.
9. Swerdlow A.J., Barber J.A., Horwich A., et al. Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital. Br J Cancer. 75:1997;116-123.
10. Swerdlow A.J., Barber J.A., Hudson G.V., et al. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort The relation to age at treatment . J Clin Oncol. 18:2000;498-509.
11. Galper S., Gelman R., Recht A., et al. Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer. Int J Radiat Oncol Biol Phys. 52:2002;406-414.
12. van Leeuwen F.E., Klokman W.J., van't Veer M.B., et al. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol. 18:2000;487-497.
13. Harvey E.B., Brinton L.A. Second cancer following cancer of the breast in Connecticut, 1935-82. Natl Cancer Inst Monogr. 68:1985;99-112.
14. Singletary S.E., Taylor S.H., Guinee V.F., et al. Occurrence and prognosis of contralateral carcinoma of the breast. J Am Coll Surg. 178:1994;390-396.
15. Bernstein J.L., Thompson W.D., Risch N., et al. Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer. Am J Epidemiol. 136:1992;925-936.
16. Raabe N.K., Sauer T., Erichsen A., et al. Breast cancer in the contralateral breast Incidence and histopathology after unilateral radical treatment of the first breast cancer . Oncol Report. 6:1999;1001-1007.
17. Hankey B.F., Curtis R.E., Naughton M.D., et al. A retrospective cohort analysis of second breast cancer risk for primary breast cancer patients with an assessment of the effect of radiation therapy. J Natl Cancer Inst. 70:1983;797-804.
18. Rosen P.P., Groshen S., Kinne D.W., et al. Contralateral breast carcinoma An assessment of risk and prognosis in stage I (T1N0M0) and stage II (T1N1M0) patients with 20-year follow-up . Surgery. 106:1989;904-910.
19. Arriagada R., Le M.G., Rochard F., et al. Conservative treatment versus mastectomy in early breast cancer Patterns of failure with 15 years of follow-up data . J Clin Oncol. 14:1996;1558-1564.
20. Broet P., De la Rochefordiere A., Scholl S.M., et al. Contralateral breast cancer Annual incidence and risk parameters . J Clin Oncol. 13:1995;1578-1583.
21. Clark R.M., Wilkinson R.H., Miceli P.N., et al. Breast cancer Experience with conservation therapy . Am J Clin Oncol. 10:1987;461-468.
22. Dewar J.A., Arriagada R., Benhamou S., et al. Local relapse and contralateral tumor rates in patients with breast cancer treated with conservative surgery and radiotherapy (Institut Gustave-Roussy 1970-1982). Cancer. 76:1995;2260-2265.
23. Kurtz J.M., Amalric R., Brandone H., et al. Contralateral breast cancer and other second malignancies in patients treated by breast-conserving therapy with radiation. Int J Radiat Oncol Biol Phys. 15:1988;277-284.
24. Montague E.D. Conservation surgery and radiation therapy in the treatment of operable breast cancer. Cancer. 53:1984;700-704.
25. Recht A., Silver B., Schnitt S., et al. Breast relapse following primary radiation therapy for early breast cancer: I. Classification, frequency and salvage. Int J Radiat Oncol Biol Phys. 11:1985;1271-1276.
26. Sarrazin D., Dewar J.A., Arriagada R., et al. Conservative management of breast cancer. Br J Surg. 73:1986;604-606.
27. Fowble B., Hanlon A., Freeman G., et al. Second cancers after conservative surgery and radiation for stages I-II breast cancer Identifying a subset of women at increased risk . Int J Radiat Oncol Biol Phys. 51:2001;679-690.
28. Mariana L., Coradina D., Biganzoli E., et al. Prognostic factors for metachronous contralateral breast cancer A comparison of the linear Cox regression model and its artificial neural network extension . Breast Cancer Res Treat. 44:1997;167-178.
29. Storm H.H., Andersson M., Boice J.D. Jr, et al. Adjuvant radiotherapy and risk of contralateral breast cancer. J Natl Cancer Inst. 84:1992;1245-1250.
30. Boice J.D. Jr, Harvey E.B., Blettner M., et al. Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med. 326:1992;781-785.
31. Cook L.S., White E., Schwartz S.M., et al. A population-based study of contralateral breast cancer following a first primary breast cancer (Washington, United States). Cancer Cause Control. 7:1996;382-390.
32. Horn P.L., Thompson W.D. Risk of contralateral breast cancer, associations with histologic, clinical, and therapeutic factors. Cancer. 62:1988;412-424.
33. Parker R.G., Grimm P., Enstrom J.E. Contralateral breast cancers following treatment for initial breast cancers in women. Am J Clin Oncol. 12:1989;213-216.
34. Storm H.H., Jensen O.M. Risk of contralateral breast cancer in Denmark 1943-80. Br J Cancer. 54:1986;483-492.
35. Ries L.A., Kosary C.L., Hankey B.F. SEER cancer statistics review, 1973-1996; tables and graphs NIH Publ No.99-2789. 1999;National Cancer Institute, Bethesda.
36. Percy C., van Holten V., Muir C. International classification of diseases for oncology. 1990;1-144 World Health Organization, Geneva, Switzerland.
37. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
38. Cox D.R. Regression models and life tables. J R Stat. 34:1972;187-229.
39. Habel L.A., Moe R.E., Daling J.R., et al. Risk of contralateral breast cancer among women with carcinoma in situ of the breast. Ann Surg. 225:1997;69-75.
40. Haagensen C.D. Bilateral carcinoma of the breast. Haagensen C.D. Breast carcinoma: risk and detection. 1981;339-379 WB Saunders, Philadelphia.
41. McVredie J.A., Inch W.R., Alderson M. Consecutive primary carcinomas of the breast. Cancer. 35:1975;1472-1477.
42. Robbins G.F., Berg J.W. Bilateral primary breast cancers A prospective clinicopathologic study . Cancer. 17:1964;1501-1527.
43. Dignam J.J. Differences in breast cancer prognosis among African-American and Caucasian women. CA Cancer J Clin. 50:2000;50-64.
44. Joslyn S.A., West M.M. Racial differences in breast carcinoma survival. Cancer. 88:2000;114-123.
45. Fraass B.A., Roberson P.L., Lichter A.S. Dose to the contralateral breast due to primary breast irradiation. Int J Radiat Oncol Biol Phys. 11:1985;485-497.
46. Mueller-Runkel R., Kalokhe U.P. Scatter dose from tangential breast irradiation to the uninvolved breast. Radiology. 175:1990;873-876.
47. 60Co. Int J Radiat Oncol Biol Phys. 17:1989;205-210.
48. Yaparpalvi R., Fontenla D.P., Yu L., et al. Radiation therapy of breast carcinoma Confirmation of prescription dose using diodes . Int J Radiat Oncol Biol Phys. 35:1996;173-183.
49. Klein E.E., Taylor M., Michaletz-Lorenz M., et al. A monoisocentric technique for breast and regional nodal therapy using dual asymmetric jaws. Int J Radiat Oncol Biol Phys. 28:1994;753-760.
50. Kelly C.A., Wang X.Y., Chu J.C.H., et al. Dose to contralateral breast A comparison of four primary breast irradiation techniques . Int J Radiat Oncol Biol Phys. 34:1996;727-732.
51. Chang S.X., Deschesne K.M., Cullip T.J., et al. A comparison of different intensity modulation treatment techniques for tangential breast irradiation. Int J Radiat Oncol Biol Phys. 45:1999;1305-1314.
52. Hong L., Hunt M., Chui C., et al. Intensity-modulated tangential beam irradiation of the intact breast. Int J Radiat Oncol Biol Phys. 44:1999;1155-1164.
53. Basco V.E., Coldman A.J., Elwood J.M., et al. Radiation dose and second breast cancer. Br J Cancer. 52:1985;319-325.
54. Veronesi U., Banfi A., Salvadori B., et al. Breast conservation is the treatment of choice in small breast cancer Long-term results of a randomized trial . Eur J Cancer. 26:1990;668-670.
55. Fisher B., Bauer M., Margolese R., et al. Five year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med. 312:1985;665-673.
56. Jacobson J.A., Danforth D.N., Cowan K.H., et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med. 332:1995;907-911.
57. Sarrazin D., Le M.G., Arragada R., et al. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol. 14:1989;177-184.
58. Zucali R., Luini A., DelVecchio M., et al. Contralateral breast cancer after limited surgery plus radiotherapy of early mammary tumors. Eur J Surg Oncol. 13:1987;413-417.
59. Julien J.-P., Bijker N., Fentiman I.S., et al. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ First results of the EORTC randomized phase III trial 10853 . Lancet. 355:2000;528-533.
60. Fisher B., Dignam J., Wolmark N., et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer Findings from National Surgical Adjuvant Breast and Bowel Project B-17 . J Clin Oncol. 16:1998;441-452.
61. Fisher B., Constantino J.P., Wickerham D.L., et al. Tamoxifen for prevention of breast cancer Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study . J Natl Cancer Inst. 90:1998;1371-1388.
62. Fisher B., Dignam J., Wolmark N., et al. Tamoxifen in treatment of intraductal breast cancer National Surgical Adjuvant Breast and Bowel Project P-24 randomized controlled trial . Lancet. 353:1999;1993-2000.
63. Polychemotherapy for early breast cancer An overview of the randomized trials . Lancet. 352:1998;930-942.
64. Veronesi U., de Palo G., Marubini E., et al. Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer. J Natl Cancer Inst. 91:1999;1847-1856.
65. Overgaad M., Jenson M.-B., Overgaad J., et al. Postoperative radiotherapy in high-risk postmenopausal breast cancer patients given adjuvant tamoxifen Danish Breast Cancer Cooperative Group DBCG 82c randomized trial . Lancet. 353:1999;1641-1648.
66. Ragaz J., Jackson S.M., Le N., et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 337:1997;956-962.